Clinical Trials Directory

Trials / Completed

CompletedNCT01950533

The Utility of Food-Specific IgE Measured With the IMMULITE 2000 Assay to Predict Symptomatic Food Allergy

Status
Completed
Phase
Study type
Observational
Enrollment
102 (actual)
Sponsor
National Jewish Health · Academic / Other
Sex
All
Age
3 Years – 21 Years
Healthy volunteers
Not accepted

Summary

Food allergy is on the rise within the pediatric population. Having food allergy can cause medical, nutritional and psychological issues in those who suffer with it. Although making the appropriate diagnosis of food allergy is very important, properly diagnosing food allergy has been a challenge. Skin prick testing and food-specific IgE testing of the blood can give positive results that are false. Currently, Oral Food Challenges are the best way to diagnose a food allergy. Unfortunately, Oral Food Challenges are time consuming and may not be readily available to suspected food allergy sufferers. This study is designed to examine the effectiveness of an allergy-detecting blood test called IMMULITE 2000 manufactured by the study sponsor, Siemens.

Conditions

Interventions

TypeNameDescription
PROCEDUREOral food challengeConfirmation of allergy to egg, milk and/or peanut through an oral food challenge or documentation of a positive oral food challenge.

Timeline

Start date
2013-09-01
Primary completion
2017-03-29
Completion
2017-03-29
First posted
2013-09-25
Last updated
2020-10-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01950533. Inclusion in this directory is not an endorsement.